Sort
64,565 grants matching “drug discovery”
Project 3: From Networks and Structures to Hierarchical Whole Cell Models of Cancer
$496,996Trey Ideker · University Of California, San Francisco · U54 · FY2025 · CA
Lipophilic antifolates and AIDS opportunistic infections
$496,945Dana-Farber Cancer Institute · R01 · FY2003 · AI
Plant Anti-HIV Agents
$496,933Kuo-Hsiung Lee · Univ Of North Carolina Chapel Hill · R01 · FY2014 · AI
(PQD5) imaging systemic tissue injuries induced by anticancer drugs
$496,930Ming Zhao · Northwestern University At Chicago · R01 · FY2017 · CA
Mechanism-based Classification and Targeting of Castration-Resistant Prostate Can
$496,917Peter S Nelson · Fred Hutchinson Cancer Research Center · RC1 · FY2010 · CA
Restoration of Tumor Suppression Activity in Malignant Melanoma
$496,909David Joseph Weber · University Of Maryland Baltimore · R01 · FY2006 · CA
PROTEINS IN MULTIPLE MYELOMA AND RELATED BLOOD DISORDERS
$496,817Alan Solomon · University Of Tennessee Knoxville · R01 · FY2011 · CA
Restoration of Tumor Suppression Activity in Malignant Melanoma
$496,770David Joseph Weber · University Of Maryland Baltimore · R01 · FY2010 · CA
Molecular Cloaking Devices for Manipulation of Cysteine Post-Translational Modifications
$496,766Thomas J. Kodadek · University Of Florida · R21 · FY2022 · CA
Product Development Core
$496,758Julian P Whitelegge · University Of California Los Angeles · U19 · FY2018 · AI
Research Core
$496,722W Kelley Thomas · University Of New Hampshire · P20 · FY2020 · GM
Preclinical validation of Kir4.1/5.1 inhibitors for overcoming diuretic resistance
$496,687Jerod S Denton · Vanderbilt University Medical Center · R01 · FY2023 · DK
North Texas Hepatitis B Consortium: Clinical Site for the Hepatitis B Network
$496,631William M Lee · Ut Southwestern Medical Center · U01 · FY2010 · DK
Development of new ADCY10 inhibitors
$496,574Jochen Buck · Weill Medical Coll Of Cornell Univ · P50 · FY2024 · HD
Development of new ADCY10 inhibitors
$496,574Jochen Buck · Weill Medical Coll Of Cornell Univ · P50 · FY2023 · HD
Development of new ADCY10 inhibitors
$496,574Jochen Buck · Weill Medical Coll Of Cornell Univ · P50 · FY2025 · HD
Drug Action, Metabolism and Kinetics Training Grant
$496,563William M Atkins · University Of Washington · T32 · FY2019 · GM
CAREER: A Data-Driven Network Inference Framework for Context-Conditioned Protein Interaction Graphs
$496,556Yanjun Qi · University Of Virginia Main Campus · · FY2015 · CSE
Genetics and Personalized Medicine: From Population Studies to Clinical Therapy
$496,501Christie M Ballantyne · Baylor College Of Medicine · P30 · FY2009 · HL
Broad spectrum antifungals targeting fatty acid biosynthesis
$496,500Glen Palmer · University Of Tennessee Health Sci Ctr · R33 · FY2019 · AI
Targeted siRNA delivery to aberrantly activated leukocytes for treating colitis
$496,477Motomu Shimaoka · Immune Disease Institute, Inc. · RC1 · FY2009 · DK
Training in Pharmacological Sciences
$496,475Joey V Barnett · Vanderbilt University · T32 · FY2014 · GM
Discovery of small molecule inhibitors for protein N-terminal acetyltransferase D
$496,475Rong Huang · Purdue University · R01 · FY2024 · CA
P7C3 based small molecule for Heart failure treatment
$496,475Srinivas M. Tipparaju · University Of South Florida · R61 · FY2025 · HL
Discovery of Potent 12-Lipoxygenase Inhibitors of Platelet Activation
$496,455Theodore R Holman · University Of California Santa Cruz · R01 · FY2014 · AG